A G-->A transition creates a branch point sequence and activation of a cryptic exon, resulting in the hereditary disorder neurofibromatosis 2.

We describe a G-->A transition within intron 5 of the NF2 gene. This mutation creates a consensus splice branch point sequence. To our knowledge this is the first report of a mutation that creates a functional branch point sequence in a human hereditary disorder. The new branch point sequence is located 18 bp upstream of a consensus splice acceptor site. A consensus splice donor site is found 106 bp 3' of the acceptor site. Asa consequence the G-->A transition results in an alternatively spliced mRNA containing an additional exon 5a of 106 bp derived from intron sequences. We cloned the mutant cDNA and show that due to an in-frame stop codon the cDNA codes for a truncated NF2 protein. The mutation was observed in three affected members of an NF2 family. In a tumour of one of the family members both alternatively spliced and wild-type mRNA were found, although the wild-type allele of the gene is absent due to an interstitial deletion on chromosome 22. We also show that immunoprecipitations reveal the presence of full-length wild-type NF2 protein in the tumour lysate. These data support the hypothesis that some degree of normal splicing of the mutant precursor RNA is taking place. It is therefore likely that this residual activity of the mutant allele explains the relatively mild phenotype in the family. These data also indicate that complete inactivation of the gene is not required for tumour formation.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  R. Hennekam,et al.  Parental somatic and germ-line mosaicism for a FBN2 mutation and analysis of FBN2 transcript levels in dermal fibroblasts. , 1997, American journal of human genetics.

[3]  M. Fornerod,et al.  Interaction of cellular proteins with the leukemia specific fusion proteins DEK-CAN and SET-CAN and their normal counterpart, the nucleoporin CAN. , 1996, Oncogene.

[4]  M. Kaiser-Kupfer,et al.  Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. , 1996, American journal of human genetics.

[5]  R. Weksberg,et al.  Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. , 1996, American journal of human genetics.

[6]  S. Jhanwar,et al.  High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[7]  T. H. van der Kwast,et al.  Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton. , 1995, The American journal of pathology.

[8]  J. Minna,et al.  Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. , 1995, Cancer research.

[9]  P. Riegman,et al.  Cytogenetic, Molecular Genetic and Pathological Analyses in 126 Meningiomas , 1995, Journal of neuropathology and experimental neurology.

[10]  A. Hagemeijer,et al.  Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. , 1994, American journal of human genetics.

[11]  J. Gusella,et al.  Exon scanning for mutation of the NF2 gene in schwannomas. , 1994, Human molecular genetics.

[12]  J. Gusella,et al.  Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types , 1994, Nature Genetics.

[13]  S. Pulst,et al.  Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 , 1993, Nature.

[14]  J. Haines,et al.  A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor , 1993, Cell.

[15]  André Rosenthal,et al.  Aberrant splicing of neural cell adhesion molecule L1 mRNA in a family with X–linked hydrocephalus , 1992, Nature Genetics.

[16]  D. Evans,et al.  A clinical study of type 2 neurofibromatosis. , 1992, The Quarterly journal of medicine.

[17]  T. Maniatis,et al.  The role of the mammalian branchpoint sequence in pre-mRNA splicing. , 1988, Genes & development.

[18]  G. Bleeker,et al.  Meningiomas in five members of a family over two generations, in one member simultaneously with acoustic neurinomas , 1978, Neurology.

[19]  E. Zwarthoff Neurofibromatosis and associated tumour suppressor genes. , 1996, Pathology, research and practice.